Download PDF
Pharmacopsychiatry 2006; 39(3): 117-118
DOI: 10.1055/s-2006-941489
Letter
© Georg Thieme Verlag KG Stuttgart · New York

Injectable Atypical Antipsychotics for Agitation in Borderline Personality Disorder

A Case ReportJ. C. Pascual1 , M. Madre1 , J. Soler1 , J. Barrachina1 , M. J. Campins1 , E. Alvarez1 , V. Pérez1
  • 1Department of Psychiatry, Sta. Creu and St. Pau Hospital, Barcelona, Spain, Universitat Autònoma de Barcelona
Further Information

Publication History

Received: 19.9.2005 Revised: 18.1.2006

Accepted: 13.2.2006

Publication Date:
23 May 2006 (online)

Also available at
    Permissions and Reprints

Agitation is relatively common among Borderline Personality Disorder (BPD) patients in Psychiatric Emergency Services (PES).New injectable atypical antipsychotics are indicated for treatment in agitated psychotic or maniac patients but not for agitated BDP patients. Twenty agitated BPD patients were treated with intramuscular atypical antipsychotics (olanzapine or ziprasidone). Results suggest intramuscular atypical antipsychotics may be effective, fast and safe for treating acute BPD patients.

References

  • 1 Allen M H. Managing the agitated psychotic patient: a reappraisal of the evidence.  J Clin Psychiatry. 2000;  61 (Suppl 14) 11 - 20
    PubMedGoogle Scholar
  • 2 American Psychiatric Association Practice Guidelines: Practice guideline for the treatment of patients with borderline personality d isorder. American Psychiatric Association.  Am J Psychiatry. 2001;  158 (Suppl 10) 1-52
    CrossrefPubMedGoogle Scholar
  • 3 Currier G W. Atypical antipsychotic medications in the psychiatric emergency service.  J Clin Psychiatry. 2000;  61 (Suppl 14) 21-26
    PubMedGoogle Scholar
  • 4 Currier G W, Allen M H, Bunney E B, Daniel D G, Francis A, Jagoda A, Zimbroff D. Standard therapies for acute agitation.  J Emerg Med. 2004;  27 (Suppl 4) S9-12
    CrossrefPubMedGoogle Scholar
  • 5 Forster A, Gardaz J P, Suter P M, Gemperle M. Respiratory depression by midazolam and diazepam.  Anesthesiology. 1980;  53 494-497
    PubMedGoogle Scholar
  • 6 Grootens K P, Verkes R J. Emerging evidence for the use of atypical antipsychotics in borderline personality disorder.  Pharmacopsychiatry. 2005;  38 20-23
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 Pascual J C, Madre M, Puigdemont D. et al .A naturalistic study: 100 consecutive episodes of acute agitation in a psychiatric emergency department. Act Esp Psiquiatr 2005: in press
    Google Scholar
  • 8 Pascual J C, Oller S, Soler J. et al . Ziprasidone in the acute treatment of borderline personality disorder in psychiatric emergency services.  J Clin Psychiatry. 2004;  65 1281-1282
    PubMedGoogle Scholar
  • 9 Soler J, Pascual J C, Campins J, Barrachina J, Puigdemont D, Alvarez E, Pérez V. Double-blind, placebo-controlled study of borderline personality disorder: Olanzapine plus dialectical behavior therapy.  Am J Psychiatry. 2005;  162 1221-1224
    CrossrefPubMedGoogle Scholar

Victor Pérez

Department of Psychiatry

Sta. Creu and St. Pau Hospital

St Antoni Mª Claret 167

08025 Barcelona

Spain

Phone: +34 93 291 9186

Fax: +34 93 291 9399

Email: vperez@hsp.santpau.es

      >